Polio - Pipeline Review, H2 2015

1
Polio - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Polio
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Polio and enlists
  all their major and minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Polio products under development
  by companies and universities/research institutes
  based on information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Polio pipeline on the basis of
  target, MoA, route of administration and molecule
  type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/polio-p
  ipeline-review-h2-2015-market

3


Table of Content
List of Figures Number of Products under
Development for Polio, H2 2015 10 Number of
Products under Development for Polio -
Comparative Analysis, H2 2015 11 Number of
Products under Development by Companies, H2 2015
12 Comparative Analysis by Late Stage
Development, H2 2015 15 Comparative Analysis by
Clinical Stage Development, H2 2015
16 Comparative Analysis by Early Stage Products,
H2 2015 17 Assessment by Monotherapy Products, H2
2015 34 Assessment by Combination Products, H2
2015 35 Number of Products by Targets, H2 2015
36 Number of Products by Stage and Targets, H2
2015 36 Number of Products by Routes of
Administration, H2 2015 38 Number of Products by
Stage and Routes of Administration, H2 2015
38 Number of Products by Molecule Types, H2 2015
40 Number of Products by Stage and Molecule
Types, H2 2015 40
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Polio Plan mergers and acquisitions
effectively by identifying key players of the
most promising pipeline Devise corrective
measures for pipeline projects by understanding
Polio pipeline depth and focus of Indication
therapeutics Develop and design in-licensing and
out-licensing strategies by identifying
prospective partners with the most attractive
projects to enhance and expand business potential
and Scope Modify the therapeutic portfolio by
identifying discontinued projects and
understanding the factors that drove them from
pipeline Enquire At http//www.researchbeam.co
m/polio-pipeline-review-h2-2015-market/enquire-abo
ut-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/polio-pipeline-review-
h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com